A new drug target in the Zika virus that can bind with an existing antimalarial drug to inhibit the spread of the disease in the human body including the pregnant woman has been discovered by IIT Mandi researchers.
Hydroxychloroquine, a drug that already has approved uses in pregnancy is a inhibitor of NS2B-NS3 protease. It significantly decreases Zika virus infection in placental cells. It is used to treat and prevent malaria and treat chikungunya arthritis can inhibit the NS2B-NS3 protease necessary for the replication of the Zika virus. For prevention of malaria 400 mg dose is used weekly)
Flavi virus diseases (Zika, dengue, chikungunya) are transmitted by the aedes aegypti mosquitoes.
Zika Fever
Zika virus is transmitted to humans by infected mosquitoes which causes mild fever with maculopapular rash. No treatment or vaccine is currently available.
Advertisement
‘NS2B-NS3 protease, the target for drugs combating Zika virus (and other flavi-viruses) pathogenicity, plays a key role in hydrolysis and maturation of the flavivirus polyprotein.’
Tweet it Now
They are self-limiting disease that causes fever, rashes, joint pain and red eyes. In pregnant women Zika is associated with babies born with microcephaly (a small head and abnormal brain development).
Speaking about this, Padma Shri Awardee, Dr KK Aggarwal, President, HCFI, said, "Prior and recent dengue virus infection is associated with protection from symptomatic Zika virus infection. Children with prior dengue infection have 38% less risk of showing symptoms when infected with Zika than those who were dengue-free".
![Test Your Knowledge on Zika Virus]( "Test Your Knowledge on Zika Virus")
Zika virus is a mosquito-borne virus that causes fever, headache, skin rashes, joint and muscle pain in infected individuals. The symptoms usually last for only 2 to 7 days. Fetal symptoms vary and have led to International concern.
Adding further, Dr Aggarwal, who is also the Group Editor-in-Chief of IJCP, said, "The need of the hour is prevention and enhanced surveillance. Use of measures to protect against mosquito bites is very important such as using insect repellent, covering as much of the body as possible with long, light-colored clothing, eliminating places where mosquitoes can breed and putting screens on windows and doors. Now the patients can ask their doctors about hydroxy-chloroquine prophylaxis)
Source: Medindia
Test Your Knowledge on Zika Virus
Zika virus is a mosquito-borne virus that causes fever, headache, skin rashes, joint and muscle pain in infected individuals. The symptoms usually last for only 2 to 7 days. Fetal symptoms vary and have led to International concern.
Advertisement
Adding further, Dr Aggarwal, who is also the Group Editor-in-Chief of IJCP, said, "The need of the hour is prevention and enhanced surveillance. Use of measures to protect against mosquito bites is very important such as using insect repellent, covering as much of the body as possible with long, light-colored clothing, eliminating places where mosquitoes can breed and putting screens on windows and doors. Now the patients can ask their doctors about hydroxy-chloroquine prophylaxis)
Source: Medindia
Good Protein Goes Rogue Helps Zika Virus
A cellular protein known to interact with invading viruses has been found to be actually helping zika virus in its infection process, finds a new study.
Advertisement
 Potential Safer Vaccine Against Zika Virus IdentifiedSafer Potential Zika Vaccine was discovered using adenovirus as a vector which induced strong T cell response with no formation of zika antibodies | Advertisement
|
Advertisement
Recommended Readings
Latest Tropical Disease News
Mumbai's TechInvention Lifecare and South Korean Eubiologics team up to introduce oral cholera vaccine in India after successful phase III clinical trial.
Scientists have found that the dengue virus has become more severe in India, highlighting the urgent need for vaccines that target the strains found in the country.
It is important to consider malarial infection in cases of acute kidney injury in someone with a travel history from endemic areas to improve treatment outcomes.
Ghana approves the use of the University of Oxford's malaria vaccine, produced by the Serum Institute of India (SII), becoming the first country to adopt the new vaccine.
The dengue virus combines molecules from its RNA with mosquito saliva to foil the human immune system and spread dengue fever and related diseases.